Had a chance to talk to our youngest son last night and he apologized for not calling or texting in the last few weeks, but told us he's been slammed at work as the Novavax COVID-19 vaccine trials have been reaching their conclusion and told us his typical day in the lab has been roughly 14 to 15 hours! Now that's busy. This will also be a two shot vaccine, but it's a protein based vaccine that is a little different than those based on mRNA technology. Trial results have been encouraging with efficacy rates in the 89 to 90 percent range, and impressive generation of neutralizing antibodies. He believes the vaccine will eventually gain FDA approval in early May, and it may be available in ample quantities for the 16 and older groups who wish to get a COVID-19 vaccine. So, unless things go awry in the final stages here's another effective vaccine about to be introduced.